The author reviews the comparative and non-comparative studies of cefe
pime and cefpirome, from which it is evident that both cephalosporins
are extremely effective both clinically and bacteriologically. Success
rates of about 90% have been reported for both drugs as therapy for c
omplicated urinary tract infections, lower respiratory tract infection
s of the community as well as of nosocomial origin, including a large
number of penicillin-resistant Streptococcus pneumoniae infections, sk
in and soft-tissue infections, surgical infections, as well as therapy
for infections in neutropenic hosts. Cure rates are similar to or bet
ter than those obtained with ceftazidime, cefotaxime and ceftriaxone.
The author also points out the various precautions necessary in utiliz
ing these two antimicrobial agents.